• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,991.22 790.54
( 1.04%)
Global Indices
Nasdaq
51,704.04 -29.67
(-0.06%)
Dow Jones
7,389.07 -104.72
(-1.40%)
Hang Seng
69,343.30 -445.08
(-0.64%)
Nikkei 225
10,453.87 25.02
(0.24%)
Forex
USD-INR
94.53 0.21
(0.22%)
EUR-INR
108.18 0.03
(0.03%)
GBP-INR
125.09 0.39
(0.31%)
JPY-INR
0.58 0.00
(0.06%)

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
539730
INE194R01017
489.430006
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
42.86
1423.32
EPS(TTM)
Face Value()
Div & Yield %
60.24
10
0.03
 

Chandra Prabhu International reports standalone net profit of Rs 5.99 crore in the March 2026 quarter
May 26,2026
Net profit of Chandra Prabhu International reported to Rs 5.99 crore in the quarter ended March 2026 as against net loss of Rs 0.12 crore during the previous quarter ended March 2025. Sales declined 45.32% to Rs 164.27 crore in the quarter ended March 2026 as against Rs 300.41 crore during the previous quarter ended March 2025.

For the full year,net profit rose 22.88% to Rs 2.90 crore in the year ended March 2026 as against Rs 2.36 crore during the previous year ended March 2025. Sales declined 39.13% to Rs 605.21 crore in the year ended March 2026 as against Rs 994.26 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales164.27300.41 -45 605.21994.26 -39
OPM %4.180.17 -0.660.61 -
PBDT6.630.19 3389 1.274.33 -71
PBT6.56-0.08 LP 0.613.23 -81
NP5.99-0.12 LP 2.902.36 23